United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. They have four approved products on the market today and they are not stopping there! From the United States to Europe to the Asia Pacific, they are proud of their multicultural business environment where employees can collaborate with people all over the world. As a group, they are relentless in their pursuit of “medicines for life”® and continue their research into treatments for pulmonary arterial hypertension, cancer, and some of the world’s most complicated viral illnesses.
SteadyMed Ltd. is a medical-device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes and other chronic conditions. The company's products are pre-filled drug-infusion patches that will be sold in conjunction with a series of pharma and device companies. Specific applications of the device will be tailored in accordance with the requirements of the company's partners.
Celularity is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
University of Alabama at Birmingham (UAB), which has been ranked among the top universities in the world, offers exceptional undergraduate and graduate academics. UAB has over 130 different areas of study from which to choose. These encompass bachelor's master's, doctoral and professional degrees in the arts, sciences, business, education, engineering and public health, among others. UAB's medical school, which features one of the largest university medical centers in the country, has been especially praised for its excellence. UAB's students are also a testament to the quality of a UAB education, with numerous Fullbright, Rhodes, Marshall, Truman and other scholars among its graduates. Student life at UAB is multifaceted and includes over 150 student organizations, vibrant Greek life, a top-ranking recreation and fitness center and year-round intramural sports. The majority of students live in residence halls. For those who need partial or full assistance covering tuition, financial aid is available to eligible students as are departmental fellowships for graduate students.
Revivicor is a regenerative medicine company focused on applying leading-edge animal biotechnology platforms to provide a superior quality, high-volume, human-compatible, alternative tissue source for treatment of human degenerative disease.
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.
Cooke Pharma
Acquisition in 2000
Cooke Pharma is a privately held company and is the exclusive maker of the HeartBar line of arginine-enriched products.
Medicomp develops, manufactures, and provides service with the most reliable and sophisticated ambulatory heart-monitoring systems.
SynQuest, Inc.
Acquisition in 1999
SynQuest, Inc. is a company that manufactured treprostinil, the bulk active ingredient in Remodulin.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.